Rekrutierung

Eingeschlossene Patienten: 18.743 (Stand 01. September 2019) 
Amgevita® (Adalimumab)38
Benepali® (Etanercept)608
Cimzia® (Certolizumab)884
Enbrel® (Etanercept)2857
Erelzi® (Etanercept)187
Flixabi® (Infliximab)2
Hulio® (Adalimumab)2
Humira® (Adalimumab)2903
Hyrimoz® (Adalimumab)40
Imraldi® (Adalimumab)30
Inflectra™ (Infliximab)16
Kevzara® (Sarilumab)96
Kineret® (Anakinra)89
MabThera® (Rituximab)1459
Olumiant® (Baricitinib)302
Orencia® (Abatacept)772
Remicade® (Infliximab)762
Remsima® (Infliximab)10
Rixathon® (Rituximab)8
RoActemra® (Tocilizumab)1315
Simponi® (Golimumab)439
Xeljanz® (Tofacitinib)237
Zessly® (Infliximab)1
Kontrollen5686